Advance in the study of complication of anti-vascular endothelial growth factor following intravitreal injection
- VernacularTitle:玻璃体内注射血管内皮生长因子抑制剂并发症的研究进展
- Author:
Lizhu, MENG
;
Song, CHEN
- Publication Type:Journal Article
- Keywords:
vitreous;
anti-VEGF drug;
complication;
choroidal neovascularization
- From:Chinese Ophthalmic Research
2009;27(11):1039-1043
- CountryChina
- Language:Chinese
-
Abstract:
The efficacy of intravitreal injection of anti vascular endothelial growth factor(VEGF) drug has been recognized for the treatment of choroidal neovascularization(CNV) secondary to age-related macular degeneration(AMD), central exudative chorioretinopathy and pathological myopia, proliferative diabetic retinopathy (PDR), retinal vein occlusion, retinopathy of prematurity and neovascular glaucoma. The tendency of clinic application of anti-VEGF is increasing. Though the therapeutic effect of anti-VEGF has been confirmed, a variety of complications associated with its usage were reported. This review summared the advancement of the complication in the clinical application of anti-VEGF therapy such as its effect on normal structure and physiological function of eye, intraocular pressure elevation, rips of retinal pigment epithelium(RRPE), retinal detachment(RD), endophthalmitis and systemic side-effects.
